Gerald L. Ray & Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Gerald L. Ray & Associates's AMGN Position: Q3 2017 in Review
Gerald L. Ray & Associates reduced its Amgen (AMGN) stake by 0.38% in Q3 2017, selling an estimated $81K and leaving 120,452 shares worth $22.5M. The position accounts for 2.8% of the portfolio, ranked #5.
Gerald L. Ray & Associates first reported a position in AMGN in Q2 2013 and has held it in 18 quarters since. 1,605 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.
- Gerald L. Ray & Associates held 120,452 shares of Amgen worth $22.5M as of Q3 2017.
- Gerald L. Ray & Associates sold 457 Amgen shares in Q3 2017, an estimated $81K.
- Amgen made up 2.8% of Gerald L. Ray & Associates's portfolio in Q3 2017, its #5 holding.
- Gerald L. Ray & Associates first reported a position in Amgen in Q2 2013 and has held it in 18 quarters since.
- 1,605 funds tracked by Wall St. Rank held Amgen as of Q3 2017.
Based on Gerald L. Ray & Associates's 13F filing for Q3 2017, filed 31 Oct 2017.